Genistein 25 g | 98%
Nature Science Technologies Ltd
Genistein
Search Results
(±)-Befunolol 5 mg | Purity Not Available
TargetMol
(±)-Befunolol
(±)-Befunolol 50 mg | Purity Not Available
TargetMol
(±)-Befunolol
(±)-Befunolol 100 mg | Purity Not Available
TargetMol
(±)-Befunolol
(±)-BI-D 1 mL | Purity Not Available
TargetMol
(±)-BI-D is an effective ALLINI(An allosteric IN inhibitor) that binds integrase at the LEDGF/p75 binding site (IC50: 2.4–2.9 μM).
More Information Supplier Page(±)-BI-D
(±)-BI-D 1 mg | Purity Not Available
TargetMol
(±)-BI-D is an effective ALLINI(An allosteric IN inhibitor) that binds integrase at the LEDGF/p75 binding site (IC50: 2.4–2.9 μM).
More Information Supplier Page(±)-BI-D
(±)-BI-D 2 mg | Purity Not Available
TargetMol
(±)-BI-D is an effective ALLINI(An allosteric IN inhibitor) that binds integrase at the LEDGF/p75 binding site (IC50: 2.4–2.9 μM).
More Information Supplier Page(±)-BI-D
(±)-BI-D 5 mg | Purity Not Available
TargetMol
(±)-BI-D is an effective ALLINI(An allosteric IN inhibitor) that binds integrase at the LEDGF/p75 binding site (IC50: 2.4–2.9 μM).
More Information Supplier Page(±)-BI-D
(±)-BI-D 10 mg | Purity Not Available
TargetMol
(±)-BI-D is an effective ALLINI(An allosteric IN inhibitor) that binds integrase at the LEDGF/p75 binding site (IC50: 2.4–2.9 μM).
More Information Supplier Page(±)-BI-D
(±)-BI-D Please inquire | >98%
BOC Sciences
Approximately 2.4-2.9 μM of BI-D was required to inhibit 50% of HIV-Luc infection of WT and Hdgfrp2 KO cells, while the IC50 decreased dramatically, to 160-200 nM, in Psip1 and double-KO cells.
More Information Supplier Page